Clinical Trial Update: A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the usability of ranibizumab prefilled syringe in patients with neovascular AMD or macular edema due to retinal vein occlusion; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Neovascular Age-related Macular Degeneration
• Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2017-07-26